Liu Xingzhi, Zhang Hongbo, Cheng Ruoyu, Gu Yanzheng, Yin Yin, Sun Zhiyong, Pan Guoqing, Deng Zhongbin, Yang Huilin, Deng Lianfu, Cui Wenguo, Santos Hélder A, Shi Qin
Department of Orthopedics , The First Affiliated Hospital of Soochow University , Orthopedic Institute , Soochow University , 708 Renmin Road , Suzhou , Jiangsu 215006 , P. R. China . Email:
Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases , Shanghai Institute of Traumatology and Orthopaedics , Ruijin Hospital , Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road , Shanghai 200025 , P. R. China . Email:
Mater Horiz. 2018 Nov 1;5(6):1082-1091. doi: 10.1039/c8mh00704g. Epub 2018 Aug 16.
Antibody-based cancer immune therapy has attracted lots of research interest in recent years; however, it is greatly limited by the easy distribution and burst release of antibodies. In addition, after the clearance of the tissue, healthy tissue regeneration is another challenge for cancer treatment. Herein, we have developed a specific immunological tissue engineering scaffold using the agonistic mouse anti-human CD40 antibody (CD40mAb) incorporated into poly(l-lactide) (PLLA) electrospun fibers through the dopamine (PDA) motif (PLLA-PDA-CD40mAb). CD40mAb is successfully incorporated onto the surface of the electrospun fibrous scaffold, which is proved by immunofluorescence staining, and the PLLA-PDA-CD40mAb scaffold has an anti-tumor effect by locally releasing CD40mAb. Therefore, this immunological electrospun scaffold has very good potential to be developed as a powerful tool for localized tumor treatment, and this is the first to be reported in this area.
近年来,基于抗体的癌症免疫疗法引起了广泛的研究兴趣;然而,抗体易于分布和快速释放极大地限制了该疗法。此外,在组织清除后,健康组织再生是癌症治疗的另一大挑战。在此,我们通过多巴胺(PDA)基序将激动型小鼠抗人CD40抗体(CD40mAb)掺入聚左旋乳酸(PLLA)电纺纤维中,开发出一种特异性免疫组织工程支架(PLLA-PDA-CD40mAb)。通过免疫荧光染色证明,CD40mAb成功掺入到电纺纤维支架表面,且PLLA-PDA-CD40mAb支架可通过局部释放CD40mAb发挥抗肿瘤作用。因此,这种免疫电纺支架作为局部肿瘤治疗的有力工具具有很大的开发潜力,这也是该领域首次报道。